1- Galán JE, Bliska JB (1996) Cross-talk between bacterial pathogens and their host cells. Annu Rev Cell Dev Biol 12: 221–255.
Find this article online 2- Galán JE, Collmer A (1999) Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284: 1322–1328.
3-Crump, J.A..,Luby, S.P.,and Mintz, E.D.(2004).The global of typhoid fever. Bull.Worled Health Organ.82.346-353.
4-Woc-Colbum,L.,and Bobak,D.A. (2009).The expanding spectrum of diseas due to salmonella:an international perspective.Curr.Infect.Dis.Rep.11,120-124
5- FAO/WHO (2002) Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada.
6- Czerucka D, Piche T, Rampal P (2007) Review article: yeast as probiotics-Saccharomyces boulardii. Aliment Pharmacol Ther 26: 767–778.
7-
Find this article online 7- Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4: 733–739.
8- Kotowska, M., Albrecht, P., and Szajewska, H. (2005). Saccharomyces boulardii in the prevention of antibiotic- associated diarrhoea in children: a randomized double- blind placebo-controlled trial. Aliment Pharmacol Ther 21, 583-590.
9- McFarland, L. V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101, 812-822.
10- McFarland, L. V. (2007). Meta-analysis of probiotics for the prevention of travelerfs diarrhea. Travel Med Infect Dis 5: 97-105. ,
11- Htwe, K., Yee, K. S., Tin, M., and Vandenplas, Y. (2008). Effect of Saccharomyces boulardii in the Treatment of Acute Watery Diarrhea in Myanmar Children: A Randomized Controlled Study. Am J Trop Med Hyg 78, 214-216.
12- Guslandi, M., Giollo, P., and Testoni, P. A. (2003). A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15, 697-698
13- Guslandi, M., Mezzi, G., Sorghi, M., and Testoni, P. A. (2000). Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 45, 1462-1464.
14- Maupas, J., Champemont, P., and Delforge, M. (1983). Treatment of irritable bowel syndrome with Saccharomyces boulardii: a double-blind, placebo-controlled-study. Med Chir Dig 12, 77-79.
15- Lilian, N.M. ; Elizabeth N.; and Jacques R. Nicoli, Protection by Lactobacillus acidophilus ufv-h2b20 against experimental oral infection with Salmonella typhimuriumin gnotobiotic and conventional mice.brazilian journal of microbiology (2001).
16- Atlas, R. M.; Brown, A. E. and Parks L. L. (1995). Laboratory Manual of Experimental Microbiology (1st Ed.). Mosby. Inc. Missouri.
17- Mahzounieh, M. ; Karimi, T., and Marjianian, R., (2006).The preventive of Saccharomyces boulardii in pathogenesis of Salmonella typhimurium in experimentally infected rats. Pak. J. of Bio.Scien., 9(4): 632-635
18-
Lin WH,
Yu B,
Lin CK,
Hwang WZ,
Tsen HY. (2007). Immune effect of heat-killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice. Appl Microbiol.; 102 (1):22-31
19- Bankroft, L. (1980). Basic histological techniques; 4th ed; an Arboer science publishers. Pp: 130-145.
20- CDC.(2009) National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2006. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC,
21- Jones, B. D. & Falkow, S. (1996). Salmonellosis: host immune responses and bacterial virulence determinants. Annu Rev Immunol 14, 533–561.
22- Gedek, B. (1999) Adherence of E.coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of S.boulardii. Mycoses 42(4): 261-64
23- Rodrigues, A. C., Cara, D. C., Fretez, S. H. G. G., Cunha, F. Q., Vieira, E. C., Nicoli, J. R. & Vieira, L. Q. (2000). Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89, 404–414.
24- Dahan, S., Dalmasso, G., Imbert, V., Peyron, J. F., Rampal, P., and Czerucka, D. (2003). Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli- induced signaling pathways in T84 cells. Infect Immun 71, 766-773
25- Dalmasso, G., Loubat, A., Dahan, S., Calle, G., Rampal, P., and Czerucka, D. (2006b). Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157, 456-465.
26- Mumy, K. L., Chen, X., Kelly, C. P., and McCormick, B. A. (2007). Saccharomyces boulardii interferes with Shigella pathogenesis by post-invasion signaling events. Am J Physiol Gastrointest Liver Physiol 294, G599-609.
)
